Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Injectable therapy, especially with dutasteride, may help with hair loss, but more research is needed.

Androgen use may increase the risk of stroke, but more research is needed.

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

A new compound shows promise as a topical treatment for hair loss.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

A few users dominate Reddit discussions on JAK inhibitors, highlighting social media's potential for tracking drug safety but needing expert oversight.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Valproate is effective for epilepsy but has side effects and requires careful monitoring.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Dutasteride effectively treats hair loss and prostate issues.

Redensyl, saw palmetto, and biotin with platelet-rich plasma is a better treatment for hair loss than Procapil with platelet-rich plasma.

PRF is promising for dental and aesthetic uses but needs more research.

TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Preoperative finasteride can help prevent and reduce transurethral resection syndrome.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Tridax procumbens shows potential for various health benefits but needs more scientific research.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.